CD4 and cancer: However, multiple studies have demonstrated that under pathological conditions such as chronic infection, cancer, and inflammation, activated CD4+ T cells can also induce the expression of NKG2A/CD94 heterodimers, particularly in Th1-skewed immune responses (Gra et al., 2007; Chang et al., 2025).